In addition, hnRNPA1 also enhanced the secretion of exo-lncFERO by GC cells, indicating that the exo-lncFERO/hnRNPA1/SCD1 axis can control the tumorigenic properties and resistance to chemotherapy of GCSCs [26]. Here, HNRNPA1 is linked to gastric cancer.